ICDM 2025

Basic and translational research 1 The next wave in medicine: harnessing the power of the microbiome Chair(s): Myung-Shik Lee, Eun Hee Koh
Thursday 25 September, 16:30~17:50
Room 2
(Vista 3, B2F)

The human microbiome is increasingly being recognized as a functional organ that plays a central role in maintaining physiological homeostasis through its interactions with the host. In this session, we will explore how the microbiome influences key biological processes, with a particular focus on the functional roles of microbiome-derived metabolites. We will also introduce a range of methodological approaches currently used in microbiome research. Through this integrated perspective, we hope to shed light on emerging insights and offer a deeper understanding of how microbiome science is reshaping our view of human health and disease.

S02-L1 Hyun Ju YouSeoul National University, Department of Food and Nutrition, Korea: Microbiome therapeutics in metabolic diseases

S02-L2 Mi Na KweonUniversity of Ulsan, Korea: Linking microbiota metabolites to host homeostasis: mechanisms and implications

S02-L3 Insuk LeeYonsei University, Department of Biotechnology, Korea: Human reference microbiome for the era of microbiome medicine

Basic and translational research 2 The next era in the metabolism: crossing pathways of aging and metabolic disease Chair(s): Jongsoon Lee, Jaemin Lee
Friday 26 September, 08:40~10:00
Room 2
(Vista 3, B2F)

The global shift toward aging populations has led to a dramatic rise in aging-associated metabolic diseases, imposing substantial social, economic, medical, and emotional burdens. Despite this, a detailed understanding of the mechanistic links between aging and metabolic disorders remains elusive. This session will feature prominent researchers presenting their current work addressing this critical issue, with a particular focus on the role of intracellular organelle stresses in both aging and metabolic syndromes.

S01-L1 Youngdae GwonSungkyunkwan University, Korea: Organelle phase separation: new mechanisms of cellular senescence

S01-L2 Feyza EnginUniversity of Wisconsin-Madison, USA: β-cell senescence heterogeneity in type 1 diabetes

S01-L3 Hongbo ZhangSun Yat-Sen University, China: Mapping human muscle cell dynamics: from development to aging

S01-L4 Juewon KimKonkuk University, Korea: Linking gut microbiota to healthy aging: 3-phenyllactic acid as a metabolic modulator of mitochondrial function and stress resilience

Basic and translational research 3 The next level in muscle: enhancing metabolism and performance Chair(s): Won-Young Lee, Dong-Hoon Kim
Friday 26 September, 13:30~14:50
Room 2
(Vista 3, B2F)

This session explores emerging strategies to enhance muscle metabolism and functional performance by integrating discoveries in immunometabolism, stem cell regulation, and endo/paracrine signaling. Recent advances reveal how immune-metabolic networks, regenerative microenvironments, and myokines converge to shape muscle adaptability and aging trajectories. By bridging mechanistic insight with translational potential, the session highlights muscle as a central node for systemic metabolic health and a key target in the fight against sarcopenia and age-related decline.

S03-L1 Maxim ArtyomovWashington University, USA: Itaconate’s immunomodulatory action is mediated by its inhibition of peroxiredoxin 5

S03-L2 Vincenzo SorrentinoNational University of Singapore, Singapore: Trigonelline is an NAD+ modulator that improves muscle function during ageing and is reduced in human sarcopenia

S03-L3 Beom-Jun KimUniversity of Ulsan, Korea: The role of circulating factors in musculoskeletal aging

S03-L4 Dongryeol RyuGIST, Korea: Discovery of a novel myokine conferring protection to aged skeletal muscle

Basic and translational research 4 Unveiling the vascular symphony: cutting-edge perspectives on atherosclerosis mechanisms and interventions Chair(s): In-Kyu Lee, Jaetaek Kim
Saturday 27 September, 08:40~10:00
Room 2
(Vista 3, B2F)

Understanding the molecular mechanisms underlying atherosclerosis is key to addressing its persistent global burden. This session spans diverse domains of vascular biology, including endothelial mechanotransduction, inflammation-driven immune responses, and metabolic regulation of cellular aging. Attendees can expect an integrative perspective on how these converging pathways shape atherosclerotic progression and offer new directions for therapeutic intervention.

S04-L1 Hanjoong JoEmory Univ & Georgia Tech, USA: Disturbed flow induces reprogramming of endothelial cells to immune-like and foam cells under hypercholesterolemia during atherogenesis

S04-L2 Hyo-Soo KimSeoul National University, Korea: PCSK9 stimulates Syk, PKCδ, and NF-κB, leading to atherosclerosis progression independently of LDL receptor

S04-L3 Hyung Chul ChoiYeungnam University, Department of Pharmacology, Korea: Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway

구분		사전등록 (~2025년 8월 20일까지)		현장등록 (2025년 9월 25일 ~ 27일)
구분		KDA회원	비회원	KDA회원	비회원
25~27일 등록	전문의(개원의, 교수, 봉직의, 전임의 포함)	KRW 280,000	KRW 350,000	KRW 370,000	KRW 450,000
25~27일 등록	전공의, 간호사, 영양사, 사회복지사, 약사, 연구원, 운동처방사, 관련분야 교수 및 기타 (군의관 및 공중보건의 포함)	KRW 180,000	KRW 230,000	KRW 250,000	KRW 270,000
One-day 등록	전문의(개원의, 교수, 봉직의, 전임의 포함)	KRW 170,000	KRW 210,000	KRW 220,000	KRW 270,000
One-day 등록	전공의, 간호사, 영양사, 사회복지사, 약사, 연구원, 운동처방사, 관련분야 교수 및 기타 (군의관 및 공중보건의 포함)	KRW 110,000	KRW 140,000	KRW 150,000	KRW 160,000
저녁 식사	전체	KRW 55,000

Program details

평점안내 (For Korean)